PL3908270T3 - Połączenie dekstrometomorfanu i bupropionu do leczenia depresji u pacjentów pochodzenia azjatyckiego - Google Patents

Połączenie dekstrometomorfanu i bupropionu do leczenia depresji u pacjentów pochodzenia azjatyckiego

Info

Publication number
PL3908270T3
PL3908270T3 PL20737928.0T PL20737928T PL3908270T3 PL 3908270 T3 PL3908270 T3 PL 3908270T3 PL 20737928 T PL20737928 T PL 20737928T PL 3908270 T3 PL3908270 T3 PL 3908270T3
Authority
PL
Poland
Prior art keywords
dextromethorphan
bupropion
combination
treating depression
asian patients
Prior art date
Application number
PL20737928.0T
Other languages
English (en)
Inventor
Herriot TABUTEAU
Original Assignee
Antecip Bioventures Ii Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antecip Bioventures Ii Llc filed Critical Antecip Bioventures Ii Llc
Publication of PL3908270T3 publication Critical patent/PL3908270T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL20737928.0T 2019-01-07 2020-01-07 Połączenie dekstrometomorfanu i bupropionu do leczenia depresji u pacjentów pochodzenia azjatyckiego PL3908270T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962789431P 2019-01-07 2019-01-07
US201962789446P 2019-01-07 2019-01-07
US201962789488P 2019-01-07 2019-01-07
US201962789451P 2019-01-07 2019-01-07
PCT/US2020/012612 WO2020146412A1 (en) 2019-01-07 2020-01-07 Combination of dextromethorphan and bupropion for treating depression

Publications (1)

Publication Number Publication Date
PL3908270T3 true PL3908270T3 (pl) 2026-02-16

Family

ID=71521902

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20737928.0T PL3908270T3 (pl) 2019-01-07 2020-01-07 Połączenie dekstrometomorfanu i bupropionu do leczenia depresji u pacjentów pochodzenia azjatyckiego

Country Status (28)

Country Link
EP (2) EP3908270B1 (pl)
JP (1) JP2022516361A (pl)
KR (2) KR20210110654A (pl)
CN (4) CN114712357A (pl)
AU (3) AU2020207261B2 (pl)
BR (1) BR112020025902A2 (pl)
CA (2) CA3223187A1 (pl)
CL (1) CL2021001810A1 (pl)
CO (1) CO2021008988A2 (pl)
CR (1) CR20210368A (pl)
DK (1) DK3908270T3 (pl)
EC (1) ECSP21051833A (pl)
ES (1) ES3051232T3 (pl)
FI (1) FI3908270T3 (pl)
HR (1) HRP20251402T1 (pl)
IL (1) IL284663A (pl)
LT (1) LT3908270T (pl)
MX (3) MX2021008247A (pl)
MY (1) MY201603A (pl)
NZ (1) NZ777261A (pl)
PE (1) PE20212249A1 (pl)
PL (1) PL3908270T3 (pl)
PT (1) PT3908270T (pl)
RS (1) RS67453B1 (pl)
SG (1) SG11202106392RA (pl)
SI (1) SI3908270T1 (pl)
SM (1) SMT202600055T1 (pl)
WO (1) WO2020146412A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12194006B2 (en) 2013-11-05 2025-01-14 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US11534414B2 (en) 2013-11-05 2022-12-27 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US11433067B2 (en) 2013-11-05 2022-09-06 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US12109178B2 (en) 2013-11-05 2024-10-08 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US11969421B2 (en) 2013-11-05 2024-04-30 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
US12569479B2 (en) 2016-05-25 2026-03-10 Antecip Bioventures Ii Llc Bupropion as a modulator of drug activity
CR20210368A (es) * 2019-01-07 2021-12-10 Antecip Bioventures Ii Llc Combinación de dextrometorfano y bupropión para el tratamiento de depresión
US12433884B2 (en) 2020-06-05 2025-10-07 Antecip Bioventures Ii Llc Compounds and combinations thereof for treating neurological and psychiatric conditions
US12472156B2 (en) 2020-06-05 2025-11-18 Antecip Bioventures Ii Llc Compounds and combinations thereof for treating neurological and psychiatric conditions
US20250073188A1 (en) 2020-06-05 2025-03-06 Antecip Bioventures Ii Llc Compounds and combinations thereof for treating neurological and psychiatric conditions
CN122440635A (zh) 2020-12-01 2026-07-24 安泰赛普生物风投二代有限责任公司 用于降低抑郁症患者的自杀风险的安非他酮和右美沙芬
CA3227072A1 (en) * 2021-07-21 2023-01-26 Antecip Bioventures Ii Llc Treatment of depression
EP4384155A4 (en) * 2021-08-09 2025-01-22 Antecip Bioventures II LLC METHODS FOR MAINTAINING REMISSION OF DEPRESSIVE SYMPTOMS
JP2025517368A (ja) * 2022-05-17 2025-06-05 アンテシップ バイオベンチャーズ トゥー エルエルシー うつ病の治療
US12036191B1 (en) 2022-06-30 2024-07-16 Antecip Bioventures Ii Llc Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan
US11717518B1 (en) 2022-06-30 2023-08-08 Antecip Bioventures Ii Llc Bupropion dosage forms with reduced food and alcohol dosing effects
US12156914B2 (en) 2022-06-30 2024-12-03 Axsome Therapeutics, Inc. Pharmaceutical compositions comprising bupropion and cysteine
US11730706B1 (en) 2022-07-07 2023-08-22 Antecip Bioventures Ii Llc Treatment of depression in certain patient populations
US12194036B2 (en) 2022-07-07 2025-01-14 Antecip Bioventures Ii Llc Combination of dextromethorphan and bupropion for treating depression
US11844797B1 (en) 2023-04-20 2023-12-19 Antecip Bioventures Ii Llc Combination of dextromethorphan and bupropion for treating depression
KR20250114110A (ko) 2022-11-28 2025-07-28 안테씨프 바이오벤쳐스 투 엘엘씨 약물 활성의 조절제로서의 부프로피온
WO2025117954A1 (en) * 2023-12-01 2025-06-05 Axsome Therapeutics, Inc. Compounds and combinations thereof for treating depression in patients
WO2025245102A2 (en) * 2024-05-21 2025-11-27 S1 Biopharma, Inc. Methods and compositions for treating sexual disorder, weight loss, weight maintenance, well-being, and self-esteem

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007092329A2 (en) * 2006-02-03 2007-08-16 Avanir Pharmaceuticals Pharmaceutical compositions for treating depression, anxiety and neurodegenerative disorders
CN107669649A (zh) * 2012-10-11 2018-02-09 Ix生物制药有限公司 固体剂型
CA2899455C (en) * 2013-01-30 2021-06-08 Pharmorx Therapeutics, Inc. Treatments for depression and other diseases with a low dose agent
EP3981403A1 (en) * 2013-11-05 2022-04-13 Antecip Bioventures II LLC Compositions and methods comprising bupropion or related compounds and dextromethorphan
US10512643B2 (en) 2013-11-05 2019-12-24 Antecip Bioventures Ii Llc Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
US9402843B2 (en) * 2013-11-05 2016-08-02 Antecip Bioventures Ii Llc Compositions and methods of using threohydroxybupropion for therapeutic purposes
TWI869633B (zh) * 2014-09-14 2025-01-11 美商阿瓦尼爾製藥股份有限公司 用於治療失智症中躁動行為之包含右旋美索芬(dextromethorphan)化合物及奎尼丁(quinidine)的藥學組成物
LT3220909T (lt) * 2014-11-21 2021-01-25 Antecip Bioventures Ii Llc Bupropionas, skirtas vaisto dekstrometorfano lygio moduliavimui plazmoje
CR20210368A (es) * 2019-01-07 2021-12-10 Antecip Bioventures Ii Llc Combinación de dextrometorfano y bupropión para el tratamiento de depresión

Also Published As

Publication number Publication date
IL284663A (en) 2021-08-31
SG11202106392RA (en) 2021-07-29
NZ777261A (en) 2024-11-29
KR20240169131A (ko) 2024-12-02
MX2021008247A (es) 2021-08-16
CN112437659B (zh) 2022-04-12
PE20212249A1 (es) 2021-11-24
FI3908270T3 (fi) 2025-11-24
CN114712356A (zh) 2022-07-08
CA3126062A1 (en) 2020-07-16
CA3223187A1 (en) 2020-07-16
EP4631571A3 (en) 2025-11-26
CN114712357A (zh) 2022-07-08
ES3051232T3 (en) 2025-12-26
AU2025203831A1 (en) 2025-06-19
EP3908270A4 (en) 2022-02-16
SMT202600055T1 (it) 2026-03-09
MX2026003977A (es) 2026-05-04
CN112437659A (zh) 2021-03-02
AU2023204348A1 (en) 2023-07-27
HRP20251402T1 (hr) 2026-01-02
AU2025203831B2 (en) 2026-06-11
LT3908270T (lt) 2025-12-10
CO2021008988A2 (es) 2021-09-09
MX2026003976A (es) 2026-05-04
AU2020207261A1 (en) 2021-07-08
RS67453B1 (sr) 2025-12-31
AU2020207261B2 (en) 2023-04-13
EP3908270B1 (en) 2025-08-27
WO2020146412A1 (en) 2020-07-16
CL2021001810A1 (es) 2022-03-04
ECSP21051833A (es) 2021-11-18
JP2022516361A (ja) 2022-02-25
CA3126062C (en) 2024-02-06
AU2023204348B2 (en) 2025-06-05
EP4631571A2 (en) 2025-10-15
CN114712358A (zh) 2022-07-08
DK3908270T3 (da) 2025-11-17
BR112020025902A2 (pt) 2021-07-13
PT3908270T (pt) 2025-11-12
CR20210368A (es) 2021-12-10
SI3908270T1 (sl) 2026-01-30
KR20210110654A (ko) 2021-09-08
MY201603A (en) 2024-03-05
EP3908270A1 (en) 2021-11-17

Similar Documents

Publication Publication Date Title
SI3908270T1 (sl) Kombinacija dekstrometorfana in bupropiona za zdravljenje depresije pri azijskih bolnikih
IL268327A (en) A pharmaceutical preparation for use in the treatment and prevention of c5-related diseases and methods for the treatment and prevention of c5-related diseases
GB2590793B (en) Cannabidiol-C1 for use as a medicament and in the treatment of epilepsy
IL282871A (en) Systems and methods for skin care
PT3545948T (pt) Utilização de aglomerado de ouro ou substância que contém aglomerado de ouro na preparação de droga para prevenção e/ou tratamento de glaucoma
EP3250609A4 (en) Il13ra alpha 2 binding agents and use thereof in cancer treatment
SG11202108331XA (en) Adjustable expiratory relief in respiratory therapy
IL280475B2 (en) Pharmaceutical preparation for use in the treatment or prevention of a C5-related disease and a method for treating or preventing a C5-related disease
IL277238A (en) Modified oligonucleotides for use in the treatment of tauopathy
IL266623A (en) A pharmaceutical preparation for use in the therapeutic treatment of cancer and complications of cancer
IL276120A (en) Devices and methods for thermal treatment of tissues
GB2588994B (en) Combar for skin and hair treatment
EA201390287A1 (ru) Теобромин в комбинации с отхаркивающим или муколитическим средствами для применения в терапии
EP3848032A4 (en) APPLICATION OF PYRROLOQUINOLINE QUINONE IN THE PREPARATION OF A MEDICINE USED FOR PREVENTING AND TREATING ACUTE ALTITUDE SICKNESS AND ACUTE ALTITUDE HYPOXIC INJURY
SG11201907400YA (en) Method for treating myopia and application in preparation of medicament
GB201919200D0 (en) Use of mir-12 in preparation of drugs for treating intrauterine adhesion and/or thin endometrum
SG11202008914WA (en) A platform and system for use in therapeutic procedures
PL3937949T3 (pl) Fitoekdyzony i ich pochodne do ich zastosowania w leczeniu upośledzenia funkcji oddechowych
IL284980B1 (en) Heteroaryl-azacyclic-oxo-amide compound, pharmaceutical preparation and pharmaceutical preparation for use in the treatment
SG10201907677QA (en) Formulations for use in the prevention and/or treatment of peripheral neuropathy and its associated diseases.
IL267534A (en) Low dose drug combinations for use in preventing and treating neuronal damage
ZA201804198B (en) Composition of olivetol and method of use reduce or inhibit the effects of tetrahydrocannabinol in the human body
SI3515399T1 (sl) Kozmetični ali farmacevtski sestavek za učvrščevanje kože, fiksiranje kože in zmanjšanje gub
IL288905A (en) diagnosis and treatment
SG11202112877XA (en) Surface treatment agent and method for manufacturing surface treatment body